UBS raised the firm’s price target on Mondelez (MDLZ) to $64 from $62 and keeps a Neutral rating on the shares. Mondelez reported stronger-than-expected Q1 EPS of 67c, driven by better organic sales growth and solid margin performance, the analyst tells investors in a research note. While 2026 guidance was reaffirmed and appears achievable, upside was largely expected to be reinvested into the business, with longer-term conviction hinging on clearer visibility into potential 2027 earnings upside, UBS adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDLZ:
